Mural Oncology Price Target Announced at $18.00/Share by HC Wainwright & Co.
Express News | Mural Oncology PLC : H.c. Wainwright Initiates Coverage With Buy Rating
Raymond James Initiates Mural Oncology(MURA.US) With Buy Rating, Announces Target Price $18
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
12 Health Care Stocks Moving In Friday's Pre-Market Session
Mural Oncology Analyst Ratings
Raymond James Initiates Mural Oncology at Strong Buy With $18 Price Target
Buy Rating Affirmed for Mural Oncology on Strong Potential of Nemvaleukin Therapy and Upcoming Milestones
Mural Oncology's Investor Day Highlights Cancer Treatment Trials
Express News | Mural Oncology To Host Virtual Investor Day, Provide New Clinical Insight Into Trial Design, Statistical Assumptions, And Progress Of Late-stage Trials Of Nemvaleukin
Mural Oncology Provides Update on ARTISTRY-7 at Investor Day
Mural Oncology Provides Update on ARTISTRY-6 Cohort 2 at Investor Day
Mural Oncology Plans to Nominate Candidate for IL-18 Program by Year-end
Mural Oncology Appoints New Director and Audit Chair
Express News | Mural Oncology Strengthens Board of Directors With the Appointment of Sachiyo Minegishi
Press Release: Mural Oncology Strengthens Board of Directors With the Appointment of Sachiyo Minegishi
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13
Buy Rating Affirmed for Mural Oncology Plc on Promising Clinical Trials and Innovative Cancer Therapies
We Think Mural Oncology (NASDAQ:MURA) Needs To Drive Business Growth Carefully